Dipyridamole treatment suppresses the HMGCS1 level through inhibition of cleavage of SREBF2 [13] and downregulates the expression of HMGCS1, c-Myc, and cyclin D1 in colon cancer cells [14]. The gene discussed is HMGCS1; the disease is colonic neoplasm.